Juthi R, Sazed S, Mareboina M, Zaravinos A, Georgakopoulos-Soares I
Int J Mol Sci. 2025; 26(5).
PMID: 40076932
PMC: 11899893.
DOI: 10.3390/ijms26052311.
Bloom M, Podder S, Dang H, Lin D
Int J Mol Sci. 2025; 26(5).
PMID: 40076561
PMC: 11900920.
DOI: 10.3390/ijms26051936.
Almawash S
Cancers (Basel). 2025; 17(5).
PMID: 40075727
PMC: 11899125.
DOI: 10.3390/cancers17050880.
Tasis A, Spyropoulos T, Mitroulis I
Cancers (Basel). 2025; 17(5).
PMID: 40075597
PMC: 11898900.
DOI: 10.3390/cancers17050749.
Higdon L, Cooney L, Serti E, Suwannasaen D, Muir V, Wiedeman A
J Immunol. 2025; 214(1):12-22.
PMID: 40073269
PMC: 11844141.
DOI: 10.1093/jimmun/vkae014.
Aspirin prevents metastasis by limiting platelet TXA suppression of T cell immunity.
Yang J, Yamashita-Kanemaru Y, Morris B, Contursi A, Trajkovski D, Xu J
Nature. 2025; .
PMID: 40044852
DOI: 10.1038/s41586-025-08626-7.
Predictors of severity and onset timing of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a retrospective analysis.
Fang Q, Qian Y, Xie Z, Zhao H, Zheng Y, Li D
Front Immunol. 2025; 16:1508512.
PMID: 40040713
PMC: 11876122.
DOI: 10.3389/fimmu.2025.1508512.
Advances in Antibody-Based Immune-Stimulating Drugs: Driving Innovation in Cancer Therapy.
Zhao R, Fan X
Int J Mol Sci. 2025; 26(4).
PMID: 40003906
PMC: 11855211.
DOI: 10.3390/ijms26041440.
Pan-cancer characterization of m6A-mediated regulation of T cell exhaustion dynamics and clinical relevancies in human cancers.
Ji W, Fang Y, Chen L, Zheng Y, Pei Y, Mei C
Mol Ther Nucleic Acids. 2025; 36(1):102465.
PMID: 39995977
PMC: 11847731.
DOI: 10.1016/j.omtn.2025.102465.
Early cytokine signatures and clinical phenotypes discriminate persistent from resolving MRSA bacteremia.
Bergersen K, Zheng Y, Rossetti M, Ruffin F, Pickering H, Parmar R
BMC Infect Dis. 2025; 25(1):231.
PMID: 39966757
PMC: 11834594.
DOI: 10.1186/s12879-025-10620-3.
Assessment of prognosis and responsiveness to immunotherapy in colorectal cancer patients based on the level of immune cell infiltration.
Liao K, Zhu M, Guo L, Gao Z, Cheng J, Sun B
Front Immunol. 2025; 16:1514238.
PMID: 39963131
PMC: 11830669.
DOI: 10.3389/fimmu.2025.1514238.
Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors.
Yildirim A, Wei M, Liu Y, Nazha B, Brown J, Carthon B
Ther Adv Med Oncol. 2025; 17:17588359251316243.
PMID: 39943944
PMC: 11815817.
DOI: 10.1177/17588359251316243.
Peripheral Blood CD4/CD8 T Cell Ratio Predicts HBsAg Clearance in Inactive HBsAg Carriers Treated with Peginterferon Alpha.
Wu F, Liu C, He L, Wang Y, Zhang X, Li M
J Clin Transl Hepatol. 2025; 13(2):130-142.
PMID: 39917468
PMC: 11797822.
DOI: 10.14218/JCTH.2024.00240.
Development of a prognostic model based on four genes related to exhausted CD8+ T cell in triple-negative breast cancer patients: a comprehensive analysis integrating scRNA-seq and bulk RNA-seq.
Shi Y, Yu Y, Zhao J, Huang L, Wang Q, Sun Q
Discov Oncol. 2025; 16(1):114.
PMID: 39899181
PMC: 11790537.
DOI: 10.1007/s12672-025-01812-z.
miR-142 deficit in T cells during blast crisis promotes chronic myeloid leukemia immune escape.
Chen F, Zhao D, Xu Y, Zhang Y, Chen M, Pathak K
Nat Commun. 2025; 16(1):1253.
PMID: 39893171
PMC: 11787332.
DOI: 10.1038/s41467-025-56383-y.
CD155 promotes the progression of colorectal cancer by restraining CD8 T cells via the PI3K/AKT/NF-κB pathway.
Liang R, Liu L, Ding D, Li Y, Ren J, Wei B
Cancer Immunol Immunother. 2025; 74(3):94.
PMID: 39891722
PMC: 11787123.
DOI: 10.1007/s00262-025-03947-y.
Dynamic Tracking of Tumor Microenvironment Modulation Using Kaede Photoconvertible Transgenic Mice Unveils New Biological Properties of Viral Immunotherapy.
Diers A, Guo Q, Li Z, Richardson E, Idris S, Willis C
Cancer Res Commun. 2025; 5(2):327-338.
PMID: 39881590
PMC: 11831061.
DOI: 10.1158/2767-9764.CRC-24-0434.
Bryostatin-1 enhances the proliferation and functionality of exhausted CD8+ T cells by upregulating MAP Kinase 11.
Li L, Zhao M, van Meurs M, Brouwers-Haspels I, den Dekker R, Wilmsen M
Front Immunol. 2025; 15:1509874.
PMID: 39877358
PMC: 11772198.
DOI: 10.3389/fimmu.2024.1509874.
Enhancing immunity during ageing by targeting interactions within the tissue environment.
Bracken O, De Maeyer R, Akbar A
Nat Rev Drug Discov. 2025; .
PMID: 39875569
DOI: 10.1038/s41573-024-01126-9.
Jun, an Oncological Foe or Friend?.
Jafri Z, Li Y, Zhang J, OMeara C, Khachigian L
Int J Mol Sci. 2025; 26(2).
PMID: 39859271
PMC: 11766113.
DOI: 10.3390/ijms26020555.